Wes (Janice) Brown

BMT specialist, Infectious disease doctor

Professor of Medicine (Blood and Marrow Transplantation) at the Stanford University Medical Center

Blood and Marrow Transplant Program

  • 875 Blake Wilbur Drive
  • Palo Alto, CA 94304
  • Phone: 650-723-0822
Learn More About the Clinic Getting Here Make An Appointment

Hematology Program

  • 875 Blake Wilbur Drive
  • Palo Alto, CA 94304
  • Phone: 650-498-6000
Learn More About the Clinic Getting Here Make An Appointment

Professional Education

Medical Education: University Of Virginia (1987) VA

Fellowship: Stanford University School of Medicine (1993) CA

Residency: Stanford University School of Medicine (1990) CA

Internship: Stanford University School of Medicine (1988) CA

BA, Stanford University, Biological Sciences (1981)

MD, University of Virginia, Hypoxemic myocardial injury (1987)

Residency, Stanford University, Internal Medicine (1990)

Fellowship, Stanford University, Infectious Diseases (1996)

Clinical Trials

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.

Sirolimus and mycophenolate mofetil as GVHD prophylaxis in myeloablative, matched-related donor hematopoietic cell transplantation
Johnston, L., Florek, M., Armstrong, R., McCune, J. S., Arai, S., & Negrin, R. (2012). Sirolimus and mycophenolate mofetil as GVHD prophylaxis in myeloablative, matched-related donor hematopoietic cell transplantation. BONE MARROW TRANSPLANTATION, 47(4), 581-588.

Early CMV Viremia Is Associated with Impaired Viral Control following Nonmyeloablative Hematopoietic Cell Transplantation with a Total Lymphoid Irradiation and Antithymocyte Globulin Preparative Regimen
Schaenman, J. M., Shashidhar, S., Rhee, C., Wong, J., Navato, S., & Brown, J. M. (2011). Early CMV Viremia Is Associated with Impaired Viral Control following Nonmyeloablative Hematopoietic Cell Transplantation with a Total Lymphoid Irradiation and Antithymocyte Globulin Preparative Regimen. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 17(5), 693-702.

Long-term outcomes in patients with high-risk myeloid malignancies following matched related donor hematopoietic cell transplantation with myeloablative conditioning of BU, etoposide and CY
Naik, S., Wong, R., Arai, S., Brown, J., Laport, G., & Johnston, L. (2011). Long-term outcomes in patients with high-risk myeloid malignancies following matched related donor hematopoietic cell transplantation with myeloablative conditioning of BU, etoposide and CY. BONE MARROW TRANSPLANTATION, 46(2), 192-199.

Treatment of Acyclovir-Resistant Herpes Simplex Virus with Continuous Infusion of High-Dose Acyclovir in Hematopoietic Cell Transplant Patients
Kim, J. H., Schaenman, J. M., Ho, D. Y., & Brown, J. My. (2011). Treatment of Acyclovir-Resistant Herpes Simplex Virus with Continuous Infusion of High-Dose Acyclovir in Hematopoietic Cell Transplant Patients. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 17(2), 259-264.

Combined Effects of Interleukin-7 and Stem Cell Factor Administration on Lymphopoiesis after Murine Bone Marrow Transplantation
Chung, B., Min, D., Joo, L. W., Krampf, M. R., Huang, J., & Weinberg, K. I. (2011). Combined Effects of Interleukin-7 and Stem Cell Factor Administration on Lymphopoiesis after Murine Bone Marrow Transplantation. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 17(1), 48-60.

A 39-Year-Old Woman With Lupus, Myositis, and a Recalcitrant Vasculopathy
Sokolove, J., Copland, A., Shirvani, S., Brown, J., Posley, K., & Chung, L. (2010). A 39-Year-Old Woman With Lupus, Myositis, and a Recalcitrant Vasculopathy. ARTHRITIS CARE & RESEARCH, 62(9), 1351-1356.

Utility of Influenza Vaccination for Oncology Patients
Pollyea, D. A., Brown, J. My., & Horning, S. J. (2010). Utility of Influenza Vaccination for Oncology Patients. JOURNAL OF CLINICAL ONCOLOGY, 28(14), 2481-2490.

Comparison of polymerase chain reaction of polymorphonuclear leukocytes and plasma identifies patients who control cytomegalovirus infection after hematopoietic cell transplantation
Vana, M. L., Formankova, D., Cha, S., Sharma, A., Potena, L., & Mocarski, E. S. (2008). Comparison of polymerase chain reaction of polymorphonuclear leukocytes and plasma identifies patients who control cytomegalovirus infection after hematopoietic cell transplantation. CLINICAL INFECTIOUS DISEASES, 47(4), 535-539.

Safety and immunogenicity of a bivalent cytomegalovirus DNA vaccine in healthy adult subjects
Wloch, M. K., Smith, L. R., Boutsaboualoy, S., Reyes, L., Han, C., & Boeckh, M. (2008). Safety and immunogenicity of a bivalent cytomegalovirus DNA vaccine in healthy adult subjects. JOURNAL OF INFECTIOUS DISEASES, 197(12), 1634-1642.

The impact of regulatory T cells on T-cell immunity following hematopoietic cell transplantation
Nguyen, V. H., Shashidhar, S., Chang, D. S., Ho, L., Kambham, N., & Negrin, R. S. (2008). The impact of regulatory T cells on T-cell immunity following hematopoietic cell transplantation. BLOOD, 111(2), 945-953.

Cytomegalovirus MCK-2 controls mobilization and recruitment of myeloid progenitor cells to facilitate dissemination
Noda, S., Aguirre, S. A., Bitmansour, A., Brown, J. M., Sparer, T. E., & Mocarski, E. S. (2006). Cytomegalovirus MCK-2 controls mobilization and recruitment of myeloid progenitor cells to facilitate dissemination. BLOOD, 107(1), 30-38.

Protection against lethal Aspergillus fumigatus infection in mice by allogeneic myeloid progenitors is not major histocompatibility complex restricted
Arber, C., Bitmansour, A., Shashidhar, S., Wang, S., Tseng, B., & Brown, J. My. (2005). Protection against lethal Aspergillus fumigatus infection in mice by allogeneic myeloid progenitors is not major histocompatibility complex restricted. JOURNAL OF INFECTIOUS DISEASES, 192(9), 1666-1671.

Stepwise development of committed progenitors in the bone marrow that generate functional T cells in the absence of the thymus
Garcia-Ojeda, M. E., Dejbakhsh-Jones, S., Chatterjea-Matthes, D., Mukhopadhyay, A., Bitmansour, A., & Strober, S. (2005). Stepwise development of committed progenitors in the bone marrow that generate functional T cells in the absence of the thymus. JOURNAL OF IMMUNOLOGY, 175(7), 4363-4373.

Risks and outcomes of invasive fungal infections in pediatric patients undergoing allogeneic hematopoietic cell transplantation
Dvorak, C. C., Steinbach, W. J., Brown, J. My., & Agarwal, R. (2005). Risks and outcomes of invasive fungal infections in pediatric patients undergoing allogeneic hematopoietic cell transplantation. BONE MARROW TRANSPLANTATION, 36(7), 621-629.

Treatment of verruca vulgaris with topical cidofovir in an immunlocompromised patient: a case report and review of the literature
Cha, S., Johnston, L., Natkunam, Y., & Brown, J. (2005). Treatment of verruca vulgaris with topical cidofovir in an immunlocompromised patient: a case report and review of the literature. TRANSPLANT INFECTIOUS DISEASE, 7(3-4), 158-161.

Exogenous administration of immunomodulatory therapies in hematopoietic cell transplantation: an infectious diseases perspective
Brown, J. My. (2005). Exogenous administration of immunomodulatory therapies in hematopoietic cell transplantation: an infectious diseases perspective. CURRENT OPINION IN INFECTIOUS DISEASES, 18(4), 352-358.

The influence of the conditions of hematopoietic cell transplantation on infectious complications
Brown, J. My. (2005). The influence of the conditions of hematopoietic cell transplantation on infectious complications. CURRENT OPINION IN INFECTIOUS DISEASES, 18(4), 346-351.

Single infusion of myeloid progenitors reduces death from Aspergillus fumigatus following chemotherapy-induced neutropenia
Bitmansour, A., Cao, T. M., Chao, S., Shashidhar, S., & Brown, J. My. (2005). Single infusion of myeloid progenitors reduces death from Aspergillus fumigatus following chemotherapy-induced neutropenia. BLOOD, 105(9), 3535-3537.

Rapamycin (sirolimus) for treatment of chronic graft-versus-host disease
Johnston, L. J., Brown, J., Shizuru, J. A., Stockerl-Goldstein, K. E., Stuart, M. J., & Chao, N. J. (2005). Rapamycin (sirolimus) for treatment of chronic graft-versus-host disease. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 11(1), 47-55.

Fungal infections in bone marrow transplant patients
Brown, J. My. (2004). Fungal infections in bone marrow transplant patients. CURRENT OPINION IN INFECTIOUS DISEASES, 17(4), 347-352.

Common lymphoid progenitors rapidly engraft and protect against lethal murine cytomegalovirus infection after hematopoietic stem cell transplantation
Arber, C., Bitmansour, A., Sparer, T. E., Higgins, J. P., Mocarski, E. S., & Brown, J. My. (2003). Common lymphoid progenitors rapidly engraft and protect against lethal murine cytomegalovirus infection after hematopoietic stem cell transplantation. BLOOD, 102(2), 421-428.

Myeloid progenitors protect against invasive aspergillosis and Pseudomonas aeruginosa infection following hematopoietic stem cell transplantation
Bitmansour, A., Burns, S. M., Traver, D., Akashi, K., Contag, C. H., & Brown, J. My. (2002). Myeloid progenitors protect against invasive aspergillosis and Pseudomonas aeruginosa infection following hematopoietic stem cell transplantation. BLOOD, 100(13), 4660-4667.

Prophylactic administration of liposomal amphotericin B is superior to treatment in a murine model of invasive aspergillosis after hematopoietic cell transplantation
Bitmansour, A., & Brown, J. My. (2002). Prophylactic administration of liposomal amphotericin B is superior to treatment in a murine model of invasive aspergillosis after hematopoietic cell transplantation. JOURNAL OF INFECTIOUS DISEASES, 186(1), 134-137.

Immunity to infections following hematopoietic cell transplantation
Brown, J. M., Weissman, I. L., & Shizuru, J. A. (2001). Immunity to infections following hematopoietic cell transplantation. CURRENT OPINION IN IMMUNOLOGY, 13(4), 451-457.

Reassessing the organization of the UL42-UL43 region of the human cytomegalovirus strain AD169 genome
Mocarski, E. S., Prichard, M. N., TAN, C. S., & Brown, J. M. (1997). Reassessing the organization of the UL42-UL43 region of the human cytomegalovirus strain AD169 genome. VIROLOGY, 239(1), 169-175.

SELECTABLE INSERTION AND DELETION MUTAGENESIS OF THE HUMAN CYTOMEGALOVIRUS GENOME USING THE ESCHERICHIA-COLI GUANOSINE PHOSPHORIBOSYL TRANSFERASE (GPT) GENE
Greaves, R. F., Brown, J. M., VIEIRA, J., & Mocarski, E. S. (1995). SELECTABLE INSERTION AND DELETION MUTAGENESIS OF THE HUMAN CYTOMEGALOVIRUS GENOME USING THE ESCHERICHIA-COLI GUANOSINE PHOSPHORIBOSYL TRANSFERASE (GPT) GENE. JOURNAL OF GENERAL VIROLOGY, 76, 2151-2160.

DRAMATIC INTERSTRAIN DIFFERENCES IN THE REPLICATION OF HUMAN CYTOMEGALOVIRUS IN SCID-HU MICE
Brown, J. M., Kaneshima, H., & Mocarski, E. S. (1995). DRAMATIC INTERSTRAIN DIFFERENCES IN THE REPLICATION OF HUMAN CYTOMEGALOVIRUS IN SCID-HU MICE. JOURNAL OF INFECTIOUS DISEASES, 171(6), 1599-1603.